CME/CE - Omnia Education

Episodes 17-29 of 29

Clinical Considerations for the Diagnosis of Endometriosis
Clinical Considerations for the Diagnosis of Endometriosis
MinuteCE®
Clinical Considerations for the Diagnosis of Endometriosis
1.75 program credits
- Linda Bradley, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
MinuteCE®
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Linda Bradley, MD
1.75 program credits
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
CME/CE
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
- Sawsan As-Sanie, MD
- Linda Bradley, MD
0.25 credits
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
MinuteCE®
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
1.75 program credits
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
CME/CE
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
0.25 credits
- Kara B. Markham, MD
- Kenneth J. Moise Jr., MD
0.25 credits
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
CME/CE
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
0.25 credits
- Warner K. Huh, MD
- Kimberly Levinson, MD, MPH
0.25 credits
Patient-Centric Approaches to Managing Migraines in the Female Patient
Patient-Centric Approaches to Managing Migraines in the Female Patient
CME/CE
Patient-Centric Approaches to Managing Migraines in the Female Patient
0.25 credits
- Jessica Ailani, MD
- Dawn C. Buse, PhD
0.25 credits
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
CME/CE
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
- Lee P. Shulman, MD, FACMG, FACOG
- Alexandra Benachi, MD, PhD
- Julien Zuber, MD, PhD
Alloimmune Neutropenia of the Fetus and Newborn
Alloimmune Neutropenia of the Fetus and Newborn
CME/CE
Alloimmune Neutropenia of the Fetus and Newborn
- Lee P. Shulman, MD, FACMG, FACOG
- Masja de Haas, MD, PhD
Alloimmune Thrombocytopenia in the Fetus and Newborn
Alloimmune Thrombocytopenia in the Fetus and Newborn
CME/CE
Alloimmune Thrombocytopenia in the Fetus and Newborn
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
- James B. Bussel, MD
0.25 credits
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
CME/CE
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
- Lee P. Shulman, MD, FACMG, FACOG
- Kenneth J. Moise Jr., MD
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
CME/CE
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
- Lee P. Shulman, MD, FACMG, FACOG
- Kenneth J. Moise Jr., MD
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
CME/CE Broadcast Replay
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
- Jennifer Caudle, DO
- Thomas C. Wright, Jr., MD

Previous
1
2
Next

2/2